Company profile for Peijia Medical

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Peijia Medical Limited was established in the Cayman Islands in 2012 with headquarter in Suzhou. The Company focuses on the high-growth interventional procedural medical device market in China, and aims to become a well-known medical device platform that provides a series of treatment solutions for structural heart and neurovascular diseases. Peijia has established set of product portfolio infrastructure and a vibrant product ...
Peijia Medical Limited was established in the Cayman Islands in 2012 with headquarter in Suzhou. The Company focuses on the high-growth interventional procedural medical device market in China, and aims to become a well-known medical device platform that provides a series of treatment solutions for structural heart and neurovascular diseases. Peijia has established set of product portfolio infrastructure and a vibrant product pipeline with 6 registered products and 20 product candidates in various stages of development.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
8 Zhongtian Street Suzhou Industrial Park, Suzhou Jiangsu Province PRC
Telephone
Telephone
(86) 512 81877166
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/peijia-medical-receives-nmpa-approval-for-taurustrio-transcatheter-aortic-valve-system-pioneering-treatment-for-aortic-regurgitation-in-china-302640106.html

PR NEWSWIRE BIO
12 Dec 2025

https://www.prnewswire.com/news-releases/peijia-medical-announces-2025-interim-results-302537514.html

PR NEWSWIRE
25 Aug 2025

https://www.prnewswire.com/news-releases/peijia-medical-announces-successful-completion-of-patient-enrollment-for-pivotal-taurustrio-transcatheter-aortic-regurgitation-clinical-trial-302046428.html

PR NEWSWIRE
29 Jan 2024

https://www.prnewswire.com/news-releases/peijia-medical-presents-early-clinical-findings-of-geminione-teer-device-at-tct-2023-301969994.html

PR NEWSWIRE
27 Oct 2023

https://www.prnewswire.com/news-releases/peija-medical-announces-first-chinese-patient-implanted-with-taurustrio-transcatheter-aortic-valve-replacement-system-301890314.html

PR NEWSWIRE
01 Aug 2023

https://www.globenewswire.com/news-release/2022/01/18/2368876/0/en/JenaValve-Announces-Strategic-Investment-and-Licensing-Agreement-with-Peijia-Medical-Limited.html

GLOBENEWSWIRE
18 Jan 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty